Oncology Drug Discovery(MSc(Res))

Oncology Drug Discovery(MSc(Res))

Master degree
12 months
Full-time
Intakes: Fall
International tuition: £20,200
Domestic tuition: £5,900

Program overview

This Masters programme will provide an excellent platform for both local and international students to be educated in the drug discovery pipeline from early target identification through to commercialisation. Students will also be offered lab based projects based on a number of aspects of the taught course, including assays development, fragment screening, hit to lead chemistry projects, novel delivery projects and molecular modelling. The taught course and the lab based projects will be provided by PIs working in both the academic (Queen’s) and Industrial/Biotech setting (Almac Discovery and Fusion Antibodies).

Study options

Study options
This program can be done
On campus

Requirements

International Students Normally a minimum of a 2.1 Honours degree, or equivalent qualification acceptable to the University, in chemistry, biochemistry, pharmacology, medicinal chemistry or other related and relevant subject acceptable to the University. Evidence of equivalent professional qualifications (MBBS, BDS or BVSc) or experience will be considered on an individual basis. English level test results Official transcript of previous documents of education For information on international qualification equivalents, check the specific information for your country on the website: http://www.qub.ac.uk/International/International-students/Your-Country/#d.en.732350

Career opportunities

This programme offers an excellent opportunity to gain training in key skills required to find employment in the current pharma industry. It will also provide an excellent background for accessing further academic education.

Campus location

Belfast , United Kingdom

You may also be interested in programs like